Approach to vasculitic neuropathies

Journal of Clinical Neuromuscular Disease

Volumn 9, Issue 1, 2007, Pages 265-276

  Lacomis, David ^a,c   Živković, Sača A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VA Pittsburgh HCS   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Peripheral neuropathy; Vasculitic neuropathy; Vasculitis

Indexed keywords

ALPHA2B INTERFERON; ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; LAMIVUDINE; PREDNISONE;

AXONAL POLYNEUROPATHY; COMPRESSION FRACTURE; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; ELECTRODIAGNOSIS; HEPATITIS C; HERPES ZOSTER; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; LEUKOPENIA; MOOD DISORDER; MUSCLE BIOPSY; NAUSEA; NERVE CONDUCTION; NEUROPATHY; NONHUMAN; OSTEOPOROSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC VASCULITIS; THROMBOSIS; VASCULITIC NEUROPATHY;

HUMANS; NERVOUS SYSTEM DISEASES; VASCULITIS;

EID: 34748859765     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31815202b3     Document Type: Review

References (67)

1. Moore PM, Richardson B. Neurology of the vasculitides and connective tissue disease. J Neurol Neurosurg Psychiatry. 1998;65:10-22.
2. Kissel JT, Mendell JR. Vasculitic neuropathy. Neurol Clin. 1992;10:761-781.
3. Harati Y, Niakan E. Clinical significance of selective nerve fascicular degeneration on sural nerve biopsy specimen. Arch Pathol Lab Med. 1986;110:195-197.
4. Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988;23:461-465.
5. Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripheral Nervous System. 2006;11:20-29.
6. Schaublin GA, Michet CJ Jr, Dyck PJ, et al. An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol. 2005;4:853-65.
7. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477-491.
8. Dyck PJB, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 1999;53:2113-2121.
9. Watts RA, Lane SE, Bentham G, et al. Epidemiology of systemic vasculitis. Arthritis Rheum. 2000;43:414-419.
10. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223-243.
11. Huynh C, Ho SL, Fong KY, et al. Peripheral neuropathy in systemic lupus erythematosus. J Clin Neurophys. 1999;16:164-168.
12. Omdal R, Henriksen OA, Mellgren SI, et al. Peripheral neuropathy in systemic lupus erythematosus. Neurology. 1991;41:808-811.
13. Hietaharju A, Jaaskelainen S, Kalimo H, et al. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve. 1993;16:1204-1212.
14. Grant IA, Hunder GG, Homburger HA, et al. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-862.
15. Živković SA, Asherman D, Lacomis D. Vasculitic neuropathy - electrodiagnostic findings and association with malignancies. Acta Neurol Scand. 2007;115:432-436.
16. Dyck PJ, Hunder GG, Dyck PJ. A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology. 1997;49:1641-1645.
17. Oddis CV, Eisenbeis CH Jr, Reidbord HE, et al. Vasculitis in systemic sclerosis: association with Sjogren's syndrome and the CREST syndrome variant. J Rheum. 1987;14:942-948.
18. Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology. 1996;47:1446-1451.
19. Authier FJ, Bassez G, Payan C, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology. 2003;60:808-812.
20. Oh SJ. Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin. 1997;15:849-863.
21. Said G, Lacroix C, Planté-Bordeneuve V, et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain. 2002;125:264-275.
22. Nemni R, Sanvito L, Quattrini A, et al. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74:1267-1271.
23. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005;252:633-641.
24. Kissel JT, Slivka AP, Warmolts JR, et al. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol. 1985;18:251-257.
25. Dyck PJ, Benstead TJ, Conn DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987;110:843-853.
26. Collins MP, Periquet MI. Non-systemic vasculitic neuropathy. Curr Opin Neurol. 2004;17:587-598.
27. Sugiura M, Koike H, Iijima M, et al. Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a comparative study. J Neurol Sci. 2006;241:31-37.
28. Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003;61:623-630.
29. Greenberg SA. P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptoms. BMC Neurol. 2002;2:10.
30. Dyck PJ, Conn DL, Okazaki H. Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc. 1972;47:461-475.
31. Cid MC, Segarra M, Garcia-Martinez A, et al. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis. Curr Rheumatol Rep. 2004;6:184-194.
32. Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol. 2005;17:41-48.
33. Younger DS. Vasculitis of the nervous system. Curr Opinion Neurology. 2004;17:317-336.
34. Fauci AS, Haynes B, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978;89:660-676.
35. Wong RC, Silvestrini RA, Savige JA, et al. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. J Clin Pathol. 1999;52:124-128.
36. Kissel JT, Collins MP, Mendell JR. Vasculitic neuropathy. In: Mendel JR, Kissel JT, and Cornblath DR, eds. Diagnosis and Management of Peripheral Nerve Disorders. New York, NY: Oxford University Press; 2001:202-232.
37. Olney RK. Neuropathies in connective tissue disease. Muscle Nerve. 1992;15:531-542.
38. Said G. Vasculitic neuropathy. Baillieres Clin Neurol. 1995;4:489-503.
39. Davies L, Spies JM, Pollard JD, et al. Vasculitis confined to peripheral nerves. Brain. 1996;119:1441-1448.
40. Chang RW, Bell CL, Hallett M. Clinical characteristics and prognosis of vasculitic mononeuropathy multiplex. Arch Neurol. 1984;41:618-621.
41. de Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol. 2001;58:1215-1221.
42. Wilbourn AJ. Nerve conduction studies. Types, components, abnormalities, and value in localization. Neurol Clin. 2002;20:305-338.
43. Seo JH, Ryan HF, Claussen GC, et al. Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study. Neurology. 2004:63:874-878.
44. Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve. 1990;13:102-105.
45. Parry GJ, Linn DJ. Conduction block without demyelination following acute nerve infarction. J Neurol Sci. 1988;84:265-273.
46. Bouche P, Leger JM, Travers MA, et al. Peripheral neuropathy is systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology. 1986;36:1598-1602.
47. Lacomis D, Giuliani MJ, Steen V, et al. Small fiber neuropathy and vasculitis. Arthritis Rheum. 1997;40:1173-1177.
48. Finkelman R, Munsat T, Mandell H, et al. Neuromuscular manifestations of Wegener's granulomatosis: a case report. Neurology. 1993;43:617.
49. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa: spectrum of angiographic findings. Radiographics. 2001;21:151-159.
50. Voskuyl AE, Hazes JM, Zwinderman AH, et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis. 2003;62:407-413.
51. Cacoub P, Saadoun D, Limal N, et al. Hepatitis C virus infection and mixed cryoglobulinemia vasculitis: a review of neurological complications. AIDS. 2005;19:S128-S134.
52. Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. 2000;55:636-643.
53. Vincent D, Dubas F, Hauw JJ, et al. Nerve and muscle microvasculitis: 50 cases. Rev Neurol. 1985;141:440-446.
54. Watts RA, Scott DG, Pusey CD, et al. Vasculitis - aims of therapy. An overview. Rheumatology. 2000;39:229-232.
55. Gorson KC. Therapy for vasculitic neuropathies. Curr Treat Options Neurol. 2006;8:105-117.
56. Zaja F, DeVita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cyroglobulinemia. Blood. 2003;101:3827-3834.
57. Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002;25:909-913.
58. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon alpha-2a in patients with chronic hepatitis C. N Engl J Med. 2000;343:1666-1672.
59. Cacoub P, Lidove O, Maisonobe T, et al. Interferonalpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46:3317-3326.
60. Steck AJ. Neurological manifestations of malignant and non-malignant dysglobulinaemias. J Neurol. 1998;245:634-639.
61. Heckmann JG, Kayser C, Heuss D, et al. Neurological mamifestations of chronic hepatitis C. J Neurol. 1999;246:486-491.
62. McMahon BJ, Heyward WL, Templin DW, et al. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiological features and long-term follow-up. Hepatology. 1989;9:97-101.
63. Guillevin L, Lhote F, Leon A, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients. J Rheum. 1993;20:289-298.
64. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to Hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine. 1995;74:238-253.
65. Misiani R, Bellavita P, Fenili D, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330:751-756.
66. Levy Y, Uziel Y, Zandman GG, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221-1223.
67. Cai FZ, Ahern M, Smith M. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol. 2006;33:1197-1198.